If your dog is eating everything in sight, losing weight regardless, and producing large volumes of pale, greasy, foul-smelling stools, exocrine pancreatic insufficiency (EPI) belongs on your radar. It’s a condition that often goes undiagnosed for months — sometimes years — because its signs overlap with a long list of other gastrointestinal problems. By the time it’s confirmed, many dogs are visibly malnourished despite an appetite that would put a teenage boy to shame.
This post covers what EPI actually is, why it happens, which dogs and cats are most at risk, how it’s diagnosed, and what treatment looks like long-term. It’s written for pet owners who want a thorough, honest explanation — not a glossy summary.
If you’re worried about your pet’s weight or digestive health and you’d prefer a vet to come to you, you can book a house call consultation here
What Is Exocrine Pancreatic Insufficiency?
The pancreas does two distinct jobs. The endocrine pancreas produces hormones — primarily insulin and glucagon — that regulate blood glucose. The exocrine pancreas produces digestive enzymes and bicarbonate, which are released into the small intestine to break down food. When the exocrine portion fails, the body loses its ability to properly digest proteins, fats, and carbohydrates, regardless of how much food the animal eats.
Exocrine pancreatic insufficiency (EPI) is the clinical syndrome that results from this failure. Without adequate lipase, protease, and amylase activity in the small intestine, nutrients pass through largely undigested. The result is malabsorption — progressive weight loss and nutrient deficiency, even in animals eating well above their normal intake (Cridge, Williams & Barko, 2024).
It’s worth being clear on what EPI is not. It is not pancreatitis (inflammation of the pancreas), though chronic pancreatitis can lead to EPI over time. It is not a dietary problem. And it is not something that will resolve with a food change alone.
How Does EPI Develop?
There are several pathways to EPI, and which one is relevant matters for prognosis and — in some cases — for understanding risk in related animals.
Pancreatic Acinar Atrophy
This is the most common cause of EPI in dogs (Steiner & Carney, 2024). The pancreatic acinar cells are the functional unit of the exocrine pancreas — they produce and secrete the digestive enzymes. In pancreatic acinar atrophy (PAA), these cells progressively degenerate and are replaced by fibrous or fatty tissue. The pancreas shrinks. Enzyme output falls. Eventually, there’s not enough functional acinar tissue remaining to support normal digestion.
In German Shepherd Dogs, PAA has a well-established hereditary component. Studies using pedigree analysis and heritability estimates suggest an autosomal recessive mode of inheritance, though the picture is likely more complex and polygenic (Batchelor et al., 2007; Wiberg, Saari & Westermarck, 2000). Early in the disease process, histological examination of the pancreas shows lymphocytic infiltration — a subclinical pancreatitis — which appears to precede the atrophy. By the time clinical signs appear, the inflammatory phase has often resolved and only the atrophy remains (Wiberg, Saari & Westermarck, 2000).
Chronic Pancreatitis
In cats, chronic pancreatitis is the primary cause of EPI (Cridge, Williams & Barko, 2024). Repeated or sustained pancreatic inflammation progressively destroys acinar tissue over time. Cats can be remarkably stoic about pancreatitis — signs are often vague and insidious — which means feline EPI secondary to chronic pancreatitis frequently isn’t picked up until significant tissue loss has already occurred.
In dogs, chronic pancreatitis can also lead to EPI, though it’s less common than PAA as the primary underlying cause. Dogs with EPI from pancreatitis tend to be older than those with PAA.
Other Causes
Pancreatic neoplasia and pancreatic duct obstruction can also reduce enzyme output, though these are relatively uncommon causes of EPI. In some cases, a dog or cat may have congenital hypoplasia of the pancreas, though this is rare.
Which Breeds Are at Risk?
Dogs
Any breed can develop EPI, but some are significantly overrepresented.
German Shepherd Dog is the poster breed for EPI, and for good reason. The hereditary PAA pathway is best characterised in this breed, and GSDs account for a substantial proportion of EPI diagnoses in the literature (Cridge, Williams & Barko, 2024). Importantly, EPI in GSDs tends to develop in young to middle-aged dogs — sometimes in animals barely out of puppyhood.
Rough-Coated Collie shares a similar hereditary predisposition to PAA, with comparable genetic, clinical, and pathological findings to those seen in GSDs (Wiberg, Saari & Westermarck, 2000).
Cavalier King Charles Spaniel has been identified as a predisposed breed in more recent literature, though the underlying mechanism appears to differ from the lymphocytic pancreatitis pathway seen in GSDs (Cridge, Williams & Barko, 2024).
Eurasier and Chow Chow are also noted in the literature as breeds with increased risk of PAA-associated EPI.
Other breeds, including mixed breeds, can certainly develop EPI — particularly via the chronic pancreatitis pathway.
Cats
EPI is less common in cats overall, and there’s no strong breed predisposition documented in the same way as in dogs. Siamese cats may be somewhat overrepresented, though the evidence is less robust. Middle-aged to older cats are more typically affected, reflecting the chronic pancreatitis aetiology (Cridge, Williams & Barko, 2024).
Age of Onset
This varies considerably depending on the underlying cause.
Dogs with PAA — particularly GSDs and Rough Collies — often develop clinical EPI between 6 months and 6 years of age (Steiner & Carney, 2024). It’s not unusual to see a two- or three-year-old German Shepherd in advanced EPI.
Dogs and cats with EPI secondary to chronic pancreatitis tend to be older, typically middle-aged to geriatric, reflecting the time required for cumulative inflammatory damage to reach the threshold of clinical insufficiency.
What Does EPI Look Like?
The clinical picture of EPI is fairly recognisable once you know what you’re looking at — though the problem is that individual signs can each point in multiple directions, which is why misdiagnosis is common.
The Core Signs
Weight loss is the defining feature. It can be dramatic — some animals lose a third of their body weight or more by the time EPI is confirmed. The weight loss occurs despite a normal or increased food intake.
Polyphagia — ravenous, persistent hunger — is seen in most dogs with EPI and reflects the body’s desperate attempt to compensate for ongoing malnutrition. Some dogs become obsessive about food; others will eat things they’d never normally touch.
Voluminous, pale, greasy stools are characteristic. The stool often has a pale yellow or grey colour, a greasy or oily texture, and an exceptionally foul odour. This reflects fat malabsorption (steatorrhoea). The volume is typically much larger than normal, even accounting for increased food intake.
Flatulence and borborygmus (audible gut sounds) are common, caused by fermentation of undigested material in the intestinal tract.
Coprophagia and pica — eating faeces or non-food items — are seen in some affected animals, likely driven by nutritional deficiency and extreme hunger.
Poor coat condition and muscle wasting develop over time, reflecting protein and fat malnutrition.
What’s Less Common
Vomiting is not a primary sign of EPI and, when present, should prompt consideration of concurrent disease. Diarrhoea in the traditional sense — frequent, urgent, watery — isn’t the most typical presentation; the stools are usually voluminous and loosely formed rather than classically diarrhoeic, though there’s considerable individual variation.
How Is EPI Diagnosed?
Serum Trypsin-Like Immunoreactivity (TLI) — The Gold Standard
The definitive test for EPI is measurement of serum trypsin-like immunoreactivity (TLI). This assay measures circulating trypsinogen and trypsin — compounds that leak from the exocrine pancreas into the bloodstream in small amounts under normal conditions. When acinar mass is reduced, serum TLI falls proportionally.
Critically, TLI assays are species-specific. The canine and feline tests are different, and the wrong assay on the wrong species is worthless. This is not a test that can be run on a general veterinary biochemistry panel — it requires a specialised reference laboratory (Texas A&M GI Laboratory is the reference standard for both canine and feline TLI).
Interpretation:
- Dogs (cTLI): ≤5.5 µg/L is diagnostic for EPI; values between 5.5 and 35 µg/L are equivocal and should be re-tested after a dietary stabilisation period (Steiner & Carney, 2024)
- Cats (fTLI): ≤8.0 µg/L is diagnostic; equivocal range 8.1–11.9 µg/L (Steiner & Carney, 2024)
The animal must be fasted for at least 12 hours before the test. A recent meal can cause a transient rise in TLI that pushes values out of the diagnostic range — a fasted sample is non-negotiable.
TLI is highly sensitive and specific for EPI when performed correctly. A clearly low result in a fasted, symptomatic animal is diagnostic. There’s rarely ambiguity at the extreme low end of the range.
Cobalamin and Folate
Serum cobalamin (vitamin B12) and folate should be measured alongside TLI in any animal with suspected EPI. Cobalamin is absorbed in the distal small intestine via a receptor-mediated process that depends on a pancreatic intrinsic factor-like protein. In EPI, this binding protein is absent, and cobalamin absorption is severely impaired. Hypocobalaminaemia is extremely common in dogs and cats with EPI and has been associated with poorer outcomes when left uncorrected (Cridge, Williams & Barko, 2024).
Folate may be elevated in dogs with concurrent small intestinal dysbiosis (see below), though this is not consistently reliable as a diagnostic marker.
Ruling Out Other Conditions
Before testing for EPI, or concurrently with it, common alternative diagnoses should be considered — intestinal parasitism, dietary indiscretion, inflammatory bowel disease, and other malabsorptive conditions. A faecal examination and basic biochemistry panel form a reasonable starting point in most cases.
If you’re a Brisbane pet owner and you’d like your dog or cat assessed at home rather than hauling them to a clinic, our mobile vet service covers Brisbane, Ipswich, Logan, Moreton Bay, Redlands and Lockyer Valley.
Treatment
EPI is almost always irreversible — once acinar tissue is lost, it doesn’t regenerate (Steiner & Carney, 2024). The goal of treatment is therefore to compensate for the missing enzyme function, correct nutritional deficiencies, and manage any concurrent conditions. With appropriate management, outcomes are generally good.
1. Pancreatic Enzyme Replacement Therapy (PERT)
This is the cornerstone of EPI management and is required for the remainder of the animal’s life. Exogenous pancreatic enzymes — typically derived from porcine (pig) pancreatic extract — are mixed with the animal’s food before each meal.
Powdered enzyme preparations are significantly more effective than tablets or capsules, which require dissolution in the gastrointestinal tract before becoming active. Products containing pancreatin powder (e.g., Pancrex, Panzym) are the standard recommendation.
The enzyme powder is mixed directly into the food. There has been debate about whether allowing an incubation period (leaving the mixed food to sit for 15–30 minutes before feeding) improves efficacy. Current evidence suggests that while it may marginally help, it is not essential for a clinical response (Westermarck & Wiberg, 2012).
The initial dose is then titrated based on clinical response — stool quality, weight gain, and appetite normalisation are the practical guides. Most owners find they can reduce the dose over time once the animal is stable, which helps manage the ongoing cost.
Cost is a genuine consideration. PERT is lifelong, and the cost of commercial enzyme preparations can be significant. Some owners use raw, fresh porcine pancreas as an alternative — it contains naturally occurring enzymes and has been shown to be effective (Westermarck & Wiberg, 2012). This is a legitimate option worth discussing with your vet, particularly given the financial reality of long-term management.
2. Dietary Management
A highly digestible, low-residue diet with moderate fat content is the current recommendation. High-fibre diets are contraindicated — they reduce the efficacy of enzyme replacement by interfering with enzyme activity and slow gastric emptying. Very high fat diets can also be problematic, particularly during the initial stabilisation phase.
Prescription gastrointestinal diets are commonly used, though some animals do well on high-quality commercial foods with appropriate digestibility profiles. Raw or home-cooked diets can work but require careful formulation to avoid deficiencies.
There is no strong evidence to support the use of fat restriction in all EPI patients, and the current consensus leans toward moderate-fat rather than low-fat diets (Cridge, Williams & Barko, 2024).
3. Cobalamin Supplementation
Any animal with confirmed hypocobalaminaemia should be supplemented. Historically, subcutaneous cobalamin injections were the preferred route because of concerns that oral supplementation wouldn’t be absorbed adequately. More recent evidence supports oral cobalamin supplementation as effective in most EPI patients, which is considerably more practical for owners (Cridge, Williams & Barko, 2024).
Cobalamin should be supplemented until serum levels are confirmed to have normalised, and ongoing monitoring is advisable. Persistent hypocobalaminaemia can impair response to treatment even when enzyme replacement is otherwise adequate.
4. Managing Concurrent Small Intestinal Dysbiosis
Disruption of the normal intestinal microbiota — previously called small intestinal bacterial overgrowth (SIBO), now more accurately termed small intestinal dysbiosis — is very common in dogs with EPI (Cridge, Williams & Barko, 2024). Undigested nutrients reaching the small intestine create an environment that allows bacterial populations to expand beyond normal limits. This secondary dysbiosis can perpetuate gastrointestinal signs even after enzyme replacement is initiated.
In most cases, successful enzyme replacement alone resolves the dysbiosis without specific antibiotic therapy. Where clinical signs persist despite adequate PERT and dietary management, a short course of antibiotics (typically tylosin or metronidazole) may be warranted — though the evidence base for long-term antibiotic use is not strong, and this should be reassessed regularly (Cridge, Williams & Barko, 2024).
The gut microbiome in EPI patients is an active area of research. Growing evidence suggests that some animals have persistent dysbiosis even after treatment initiation, which may explain why a subset of patients are harder to stabilise (Cridge, Williams & Barko, 2024).
5. Addressing Concurrent Disease
In cats especially, EPI may co-exist with other gastrointestinal conditions — inflammatory bowel disease and hepatic disease are commonly concurrent in feline patients with chronic pancreatitis. These need to be identified and managed alongside the EPI. Dogs can similarly have concurrent enteropathies that complicate the clinical picture, and these should be considered in animals that fail to respond as expected.
Prognosis
The long-term prognosis for dogs and cats with EPI is generally good, provided treatment is consistent and well-managed (Cridge, Williams & Barko, 2024). Most animals begin to gain weight within a few weeks of starting PERT. Stool quality usually improves significantly within the first one to two weeks in responsive patients.
A subset of animals — estimates vary, but perhaps 20% or more — have persistent signs despite appropriate treatment (Cridge, Williams & Barko, 2024). In these cases, the most productive next steps are:
- Confirming the enzyme dose is genuinely adequate (dose too low is a common cause of treatment failure)
- Ensuring the diet is appropriate
- Checking and correcting cobalamin status
- Investigating and treating concurrent dysbiosis or enteropathy
- Reconsidering the diagnosis if response has been nil from the outset
The condition is irreversible in most cases — there’s no point at which PERT can be discontinued because the pancreas has ‘recovered’. Owners need to understand from the outset that this is lifelong management. That’s not a minor commitment, and it’s worth having an honest conversation about the practical and financial aspects before committing to a treatment plan.
A Note on Diagnosis Timing
One of the more frustrating realities of EPI is how long it can take to reach a correct diagnosis. The signs — weight loss, altered stools, increased appetite — are common to many conditions, and not all veterinarians will jump immediately to TLI testing. It’s not unusual to see EPI dogs that have been through multiple rounds of dietary trials and dewormers before the right test is run.
If your dog or cat fits the profile — particularly a young German Shepherd or any dog with progressive weight loss and ravenous appetite despite otherwise normal-seeming health — push for a TLI test early. It’s a single blood test, and it either rules EPI in or out definitively.
As a mobile veterinarian covering Brisbane and surrounding areas, I can assess your pet at home and arrange the appropriate diagnostics without the stress of a clinic visit. If this sounds relevant to your situation, you can find out more about how our at-home vet service works — PMV
Summary
Exocrine pancreatic insufficiency is a well-characterised, manageable condition, but it requires accurate diagnosis and a genuine commitment to lifelong treatment. The key points:
- EPI results from insufficient production of digestive enzymes by the exocrine pancreas
- The most common cause in dogs is pancreatic acinar atrophy (hereditary, especially in German Shepherds and Rough Collies); in cats, chronic pancreatitis
- Classic signs are progressive weight loss, polyphagia, and pale, greasy, voluminous stools
- Diagnosis is via serum TLI (species-specific, fasted sample) — it’s reliable and definitive
- Treatment requires lifelong pancreatic enzyme replacement, appropriate diet, and cobalamin supplementation
- Prognosis is generally good with consistent management, but concurrent conditions should always be investigated in animals that don’t respond as expected
If you have questions about this condition or you’d like your pet assessed, I’m happy to help.
Book a house call consultation
References
Batchelor, D.J., Noble, P.J., Taylor, R.H., Day, M.J. & German, A.J. (2007). Prognostic factors in canine exocrine pancreatic insufficiency: prolonged survival is likely if clinical remission is achieved. Journal of Veterinary Internal Medicine, 21(1), pp.54–60. https://doi.org/10.1892/0891-6640(2007)21[54:PFICEP]2.0.CO;2
Cridge, H., Williams, D.A. & Barko, P.C. (2024). Exocrine pancreatic insufficiency in dogs and cats. Journal of the American Veterinary Medical Association, 262(2). https://doi.org/10.2460/javma.23.09.0505
Steiner, J.M. & Carney, P. (2024). Exocrine pancreatic insufficiency in dogs and cats. Merck Veterinary Manual. Available at: https://www.merckvetmanual.com/digestive-system/the-exocrine-pancreas/exocrine-pancreatic-insufficiency-in-dogs-and-cats [Accessed 14 June 2026].
Texas A&M Gastrointestinal Laboratory (2024). Serum trypsin-like immunoreactivity (TLI). Available at: https://vetmed.tamu.edu/gilab/service/assays/tli/ [Accessed 14 June 2026].
Westermarck, E. & Wiberg, M. (2012). Exocrine pancreatic insufficiency in the dog: historical background, diagnosis, and treatment. Topics in Companion Animal Medicine, 27(3), pp.96–103. https://doi.org/10.1053/j.tcam.2012.05.001
Wiberg, M.E., Saari, S.A.M. & Westermarck, E. (2000). Exocrine pancreatic atrophy in German Shepherd Dogs and Rough-Coated Collies: an end result of lymphocytic pancreatitis. Veterinary Pathology, 37(6), pp.530–538. https://doi.org/10.1354/vp.37-6-530
Xenoulis, P.G. & Steiner, J.M. (2010). Lipid metabolism and hyperlipidemia in dogs. The Veterinary Journal, 183(1), pp.12–21. [Referenced for cobalamin and folate interpretation context]
Dr Stuart Cunningham BVSc — Personalised Mobile VetMobile veterinary services across Brisbane, Ipswich, Logan, Moreton Bay, Lockyer Valley and surrounds
